Aurobindo Pharma Limited has informed the Exchange regarding a press release dated May 13, 2025, titled "CuraTeQ Biologics receives approval for biosimilar Zefylti from UK s MHRA".
Press Release May 13 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Aurobindo Pharma
- Press Release Apr 26 2025
- Press Release Apr 23 2025
- Press Release Apr 12 2025
- Press Release Apr 09 2025
- Press Release Feb 06 2025
Later from Aurobindo Pharma
- Press Release May 26 2025
- Press Release Aug 04 2025
- Press Release Nov 05 2025
- Kargo.ai Raises $42M Series B to Scale Global Warehouse Deployment with Enterprise Clients
- Press Release Feb 09 2026
Follow Aurobindo Pharma into a list and get an email when it puts out news.
Follow Aurobindo Pharma